CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-30 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −42,930 | 104,367 | ||
| 2018-01-30 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −90,000 | 56,250 | ||
| 2018-01-30 | WELCH WILLIAM J Chief Executive Officer | Exercise or conversion | +130,000 | 904,655 | ||
| 2018-01-30 | WELCH WILLIAM J Chief Executive Officer | Shares withheld for taxes | −62,010 | 842,645 | ||
| 2018-01-30 | WELCH WILLIAM J Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −130,000 | 150,000 | ||
| 2018-01-23 | BRANCACCIO JOHN P Director | Grant or award · Stock Options | +54,322 | 246,130 | ||
| 2018-01-23 | Billings Paul Director | Grant or award · Stock Options | +54,322 | 175,658 | ||
| 2018-01-23 | Markin Rodney S Director | Grant or award · Stock Options | +54,322 | 160,658 | ||
| 2018-01-23 | Erlander Mark Chief Scientific Officer | Grant or award · Stock Options | +672,189 | 1,782,189 | ||
| 2018-01-23 | WELCH WILLIAM J Chief Executive Officer | Grant or award · Stock Options | +662,500 | 1,412,500 | ||
| 2018-01-23 | Countouriotis Athena Director | Grant or award · Stock Options | +54,322 | 92,428 | ||
| 2018-01-23 | ADAMS THOMAS PHD Director | Grant or award · Stock Options | +54,322 | 467,277 | ||
| 2018-01-23 | JACOB GARY S Director | Grant or award · Stock Options | +54,322 | 248,101 | ||
| 2018-01-23 | Tennant Stanley Director | Grant or award · Stock Options | +54,322 | 185,586 | ||
| 2018-01-02 | WELCH WILLIAM J Chief Executive Officer | Exercise or conversion | +50,000 | 800,142 | ||
| 2018-01-02 | WELCH WILLIAM J Chief Executive Officer | Shares withheld for taxes | −25,487 | 774,655 | ||
| 2018-01-02 | WELCH WILLIAM J Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −50,000 | 280,000 | ||
| 2018-01-02 | Tennant Stanley Director | Exercise or conversion | +16,667 | 226,061 | ||
| 2018-01-02 | Tennant Stanley Director | Exercise or conversion · Restricted Stock Units | −16,667 | 0 | ||
| 2018-01-02 | Billings Paul Director | Exercise or conversion | +16,667 | 23,165 |
Page 11 of 15 · 299 trades